Supreme Court delays ruling on Trump's National Guard deployment to Illinois, seeking clarification on the scope of presidential authority to use troops for domestic law enforcement without state consent.
Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
Novo Nordisk makes a bold $9B bid to acquire Metsera, a U.S. biotech firm, in a bid to outpace Pfizer's existing $4.9B deal and regain leadership in the competitive obesity drug market.
Supreme Court delays ruling on Trump's National Guard deployment to Illinois, seeking clarification on the scope of presidential authority to use troops for domestic law enforcement without state consent.
Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
Novo Nordisk makes a bold $9B bid to acquire Metsera, a U.S. biotech firm, in a bid to outpace Pfizer's existing $4.9B deal and regain leadership in the competitive obesity drug market.